학술논문
Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day
Document Type
Article
Author
Source
In Schizophrenia Research November 2012 141(2-3):144-152
Subject
Language
ISSN
0920-9964